The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor microenvironment
Pan Zhang, Chao Qin, Nan Liu, Xinyuan Zhou, Xuxin Chu, Fangnan Lv, Yongwei Gu, Lifang Yin, Jiyong Liu, Jianping Zhou, Meirong Huo
Topics & Concepts
Tumor microenvironmentTriple-negative breast cancerCancer researchImmunotherapyCancer immunotherapyImmunogenicityChemistryCancerBiologyMedicineBreast cancerAntigenImmunologyImmune systemTumor cellsInternal medicineNanoplatforms for cancer theranosticsImmunotherapy and Immune ResponsesCancer, Stress, Anesthesia, and Immune Response